The Janssen COVID-19 Vaccine: What Pharmacists Need to Know
On February 27, the FDA authorized the emergency use of a COVID-19 vaccine developed by the Johnson & Johnson subsidiary, Janssen Biotech – the third such vaccine to be so authorized.
What do pharmacists need to know about this product? Our guests are Michael Hogue, President of APhA and a member of the CDC working group on COVID vaccines, and Stephan Foster, APhA’s liaison to the CDC’s Advisory Committee on Immunization Practices.
Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative